Why the follow-up question is harder than the treatment question
When someone is first diagnosed with liver cancer, the immediate question is usually about treatment: surgery, ablation, embolisation, radiotherapy, systemic therapy or a combination. Follow-up is a different problem. It stretches over years, it involves more than one specialty, and it depends on details that are often scattered across several hospitals.
Liver cancer follow-up is complicated because the liver itself is part of the picture. Many patients also have underlying liver disease, such as cirrhosis or chronic hepatitis, which needs its own monitoring alongside any cancer surveillance. That means follow-up is rarely owned by one clinician. A hepatobiliary surgeon, a medical oncologist, a hepatologist and an interventional radiologist may each hold part of the plan.
For an overseas patient, the practical risk is not that follow-up is unavailable. It is that the plan becomes fragmented: scans done in one country, blood tests in another, and nobody holding the full timeline. The goal of planning care in China is therefore not only to arrange appointments, but to establish a written follow-up structure you can carry with you.
The records that make a follow-up plan possible
A receiving clinician cannot design surveillance without knowing what has already happened. The most useful starting point is a chronological summary of your liver cancer treatment, not a folder of unsorted reports.
For the tumour itself, the key items are the original pathology or biopsy report, the staging assessment, and a record of every treatment with dates and intent. If you had surgery, the operation note and the pathology report from the resected specimen matter. If you had ablation, embolisation or radiotherapy, the treatment summary should state the target and the technique used. If you had systemic therapy, the drug names, cycles completed and reason for stopping are all relevant.
For liver function, the picture is different. You need recent blood tests showing liver enzymes, bilirubin, albumin, clotting measures and platelet count, plus any imaging that describes the liver background. If you have cirrhosis, the record should say how it was diagnosed and whether you have had complications such as ascites or varices. If you have chronic hepatitis B or C, the viral status and any antiviral treatment belong in the summary.
Imaging is the third pillar. Follow-up decisions depend heavily on comparison, so the actual images matter more than the radiologist's conclusion alone. Ask for the imaging on disc or through a secure link, not only the written report. A new team can then compare directly rather than relying on a description.
You do not need to send everything at the first contact. A short summary of the diagnosis, treatments and current question is enough to start. The fuller record can follow once a clinician has agreed to review it.
- A one-page timeline: diagnosis date, staging, each treatment with dates, and current status.
- Pathology and operation reports, including the resection specimen report if surgery was performed.
- Recent liver function blood tests and any viral hepatitis results.
- Imaging on disc or secure link, plus the written reports.
- A list of current medicines, including antivirals and any supportive care.
What a handover to a Chinese team actually involves
A handover is not a single transfer of documents. It is an agreement about who is responsible for what. Before you travel, it is worth being explicit about three things: who will review your records, what they will be reviewing for, and what they will and will not be able to conclude from a paper file.
A records-based review can assess your history, comment on the coherence of the previous plan and suggest what surveillance might reasonably include. It cannot examine you, cannot perform imaging, and cannot confirm whether a specific treatment is suitable for you now. That distinction matters. A review is a starting point for a conversation, not a final decision.
If you are considering radiotherapy as part of your history or your future options, it helps to understand that radiotherapy is not one thing. The technique and schedule depend on the individual treatment plan, and the same diagnosis can be approached in different ways depending on the target, the surrounding liver and what has been done before. A follow-up discussion should therefore ask what was actually delivered, not just whether radiotherapy was used.
The handover should also address the return journey. If you plan to have some monitoring in China and some at home, the receiving team needs to know which results will be sent where, in what format, and who will act on an abnormal finding. Without that, a normal-looking scan in one system can sit unread in another.
Questions to ask before committing to follow-up in China
The useful questions are not about reputation. They are about the mechanics of your own surveillance. Ask them in writing if you can, because the answers become the plan.
First, ask what the proposed follow-up schedule is based on. A clinician should be able to explain why particular tests are suggested at particular intervals for your situation, and what would change the schedule. If the answer is vague, that is worth noting.
Second, ask who owns each part of the plan. If imaging is done at one hospital and blood tests at another, who reviews them together? Who decides whether a change on a scan needs action? Who do you contact between appointments if something feels wrong?
Third, ask how results and recommendations will reach your clinicians at home. Some patients want a written summary in English after each visit. Others want imaging shared directly. Whatever you choose, confirm that the receiving team can provide it and in what form.
Fourth, ask what the plan does not cover. Follow-up for liver cancer often includes surveillance for recurrence, monitoring of liver function and management of symptoms or treatment side effects. These are different tasks and may sit with different clinicians. Knowing the boundaries prevents gaps.
Finally, ask about the practical side: how appointments are scheduled, how long a visit is expected to take, and what preparation is needed beforehand. These are administrative questions, but they affect whether a follow-up plan is realistic for someone travelling from abroad.
Coordinating follow-up across two health systems
Many overseas patients do not move their care entirely to China. They use a period of care in China to clarify a question, then continue monitoring at home. That model can work well, but only if the two systems are connected deliberately.
The connection points are usually records, imaging and communication. Records should travel with you in a form the next clinician can read quickly. Imaging should travel in a form that can be compared, not just described. Communication should have a named route: an email address, a portal or a coordinator who knows your case.
It is also worth deciding in advance what would trigger a return to China. If a follow-up scan at home shows a change, would you seek a review remotely first, or travel? Having that answer before it is needed reduces pressure later. This is a personal decision, but it should be made with the clinical team's input about what can and cannot be assessed remotely.
Language is part of coordination. If your home records are not in English or Chinese, ask whether a translation is needed and who will provide it. A clinician reviewing a file in a third language may miss detail that matters.
A practical next step
Start with a short summary rather than a complete archive. Describe the diagnosis, the treatments you have had, your current liver status and the specific follow-up question you want answered. That is enough for an initial review to identify what is missing and which specialty should look at it.
An initial enquiry is free and does not commit you to anything. If a records-based opinion would help, that can be discussed separately; it is optional and not a prerequisite for every appointment. The treating hospital, not a coordination service, decides whether your case is suitable for care there.
The most useful thing you can do now is write your own one-page timeline. It will clarify your question, and it will be the first document any clinician reads.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.